| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/2014 | CN102380085B Veterinary-use compound medication composition for fever abatement and respiratory tract infection resistance |
| 04/16/2014 | CN102372630B Resorcinol derivative with antitumor activity, its preparation method and application |
| 04/16/2014 | CN102369195B Autotaxin inhibitors |
| 04/16/2014 | CN102341166B Dispersion composition and manufacturing method therefor |
| 04/16/2014 | CN102333773B Mineralocorticoid receptor antagonist and methods of use |
| 04/16/2014 | CN102333754B Loxoprofen derivative and pharmaceutical containing same |
| 04/16/2014 | CN102333527B Serine palmitoyltransferase inhibitors for preventing and delaying retinitis pigmentosa |
| 04/16/2014 | CN102311395B Quinazoline ring substituted diphenylurea derivative and its purpose |
| 04/16/2014 | CN102293829B Externally applying medicine for relieving pain and preparation method thereof |
| 04/16/2014 | CN102283870B High-purity folium ginkgo composition, preparation including same and preparation method thereof |
| 04/16/2014 | CN102274366B Traditional Chinese medicine composition for promoting blood circulation, promoting subsidence of swelling and relieving pain, and preparation method and application thereof |
| 04/16/2014 | CN102266367B Medicinal composition for treating alcoholic liver injury |
| 04/16/2014 | CN102264725B 蛋白激酶抑制剂 Protein kinase inhibitors |
| 04/16/2014 | CN102256977B Purine compounds |
| 04/16/2014 | CN102245597B Compounds useful for inhibiting CHK1 |
| 04/16/2014 | CN102245560B Ethoxy diphenyl ethane derivates, preparation processes and uses thereof |
| 04/16/2014 | CN102245190B 抗微生物组合物 Antimicrobial composition |
| 04/16/2014 | CN102240282B Potassium dehydroandrographolide succinate oral pharmaceutical composition and preparation method thereof |
| 04/16/2014 | CN102229528B Method for extracting unsaturated fatty acid composition from humen amniotic epithelial cells, and application thereof |
| 04/16/2014 | CN102216298B Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors |
| 04/16/2014 | CN102202659B Therapeutic, dietary, or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3, and compositions containing these compounds |
| 04/16/2014 | CN102183656B A method and kit for detecting the early onset of renal tubular cell injury |
| 04/16/2014 | CN102178670B Nitrate esters and their use for the treatment of muscle and muscle related diseases |
| 04/16/2014 | CN102164900B 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives |
| 04/16/2014 | CN102164606B Light-stabilized pharmaceutical composition |
| 04/16/2014 | CN102159539B A new metformin glycinate salt for blood glucose control |
| 04/16/2014 | CN102143940B Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists |
| 04/16/2014 | CN102106906B Traditional Chinese medicine composition and preparations thereof for freshening breath and cleansing oral cavities |
| 04/16/2014 | CN102091054B Progesterone preparation composite and preparation method thereof |
| 04/16/2014 | CN102066378B 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazine derivatives as MET kinase inhibitors |
| 04/16/2014 | CN102066366B Novel substituted pyridin-2-ones and pyridazin-3-ones |
| 04/16/2014 | CN102046185B Composition comprising 1, 3 /1, 6 beta glucan for reducing weight |
| 04/16/2014 | CN102038672B Medicinal composition for treating acne |
| 04/16/2014 | CN102020537B Protein tyrosine phosphatase 1B (PTP1B) inhibitor, and synthesis and application thereof |
| 04/16/2014 | CN102001963B Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate |
| 04/16/2014 | CN101993388B Dimerization cassaine alkaloids as well as preparation method, pharmaceutical compositions and applications of dimerization cassaine alkaloids |
| 04/16/2014 | CN101991585B Percutaneous absorption film coating agent for treating rheumatoid arthritis and preparation method thereof |
| 04/16/2014 | CN101970425B Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts |
| 04/16/2014 | CN101959846B Novel salts of O-desmethyl-venlafaxine |
| 04/16/2014 | CN101918395B Triazole oxadiazoles derivatives |
| 04/16/2014 | CN101891792B Triterpene compounds in salvia miltiorrhiza flower and extraction method and application thereof |
| 04/16/2014 | CN101824102B N-(ethylamino) inulin and preparation and application thereof |
| 04/16/2014 | CN101822657B Pachysandra terminalis alkaloid compound for resisting tumor metastasis |
| 04/16/2014 | CN101805343B Chemically modified small molecules |
| 04/16/2014 | CN101801960B Prodrugs to thyroid hormone analogs |
| 04/16/2014 | CN101754678B Short acting phenylalkylamine calcium channel blockers and uses thereof |
| 04/16/2014 | CN101700342B Pharmaceutical composition for treating hepatitis B and preparation method thereof |
| 04/16/2014 | CN101642467B Long-acting disinfection paste |
| 04/16/2014 | CN101591332B Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof |
| 04/16/2014 | CN101547932B Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus |
| 04/16/2014 | CN101500418B Method of inhibiting the transmission of influenza virus |
| 04/16/2014 | CN101496799B Use of aromatic skin-active ingredients in preparing composition for resisting skin aging |
| 04/16/2014 | CN101366699B Novel lipid composition aerosol for controlled release of active pharmaceutical ingredient via inhalation |
| 04/16/2014 | CN101360717B Compound including pyrimidine |
| 04/16/2014 | CN101291658B Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 04/15/2014 | US8697911 Rho kinase inhibitors |
| 04/15/2014 | US8697883 Cyclopenta[C]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof |
| 04/15/2014 | US8697880 Compounds useful for the synthesis of S- and R-omeprazole and a process for their preparation |
| 04/15/2014 | US8697877 Oxyindole derivatives with motilin receptor agonistic activity |
| 04/15/2014 | US8697874 Heterocyclic compound and use thereof |
| 04/15/2014 | US8697873 Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| 04/15/2014 | US8697870 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 04/15/2014 | US8697869 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators |
| 04/15/2014 | US8697868 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| 04/15/2014 | US8697865 Cyclic amide derivative, and its production and use |
| 04/15/2014 | US8697863 Fused heterocyclic compounds as ion channel modulators |
| 04/15/2014 | US8697755 Beta 2 adrenergic receptor agonists such as terbutaline for use in the treatment of nocturnal hypoglycemia |
| 04/15/2014 | US8697754 Aminoalcohol and biocide compositions for aqueous based systems |
| 04/15/2014 | US8697753 Method of treating onychomycosis |
| 04/15/2014 | US8697752 Grease-like gel for repelling insects and preventing undesirable behavior in hoofed animals |
| 04/15/2014 | US8697751 Pharmaceutical composition containing prostaglandin |
| 04/15/2014 | US8697749 Lipotoxicity relieving agent |
| 04/15/2014 | US8697748 Glycogen or polysaccharide storage disease treatment method |
| 04/15/2014 | US8697746 Solid dispersion of alpha-ketoamide derivatives |
| 04/15/2014 | US8697745 Pharmaceutical and food compositions for preventing or treating diabetes or obesity |
| 04/15/2014 | US8697744 Substituted 5,6-dihydro-4H-thiazolo[4,5-E]indazoles and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 04/15/2014 | US8697743 Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof |
| 04/15/2014 | US8697742 BCRP/ABCG2 inhibitor |
| 04/15/2014 | US8697741 Process for the preparation of amorphous calcium salt of atorvastatin |
| 04/15/2014 | US8697740 Crystalline polymorphic forms of an antidiabetic compound |
| 04/15/2014 | US8697739 Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof |
| 04/15/2014 | US8697738 Alpha-aminoamide derivatives useful in the treatment of addictive disorders |
| 04/15/2014 | US8697737 Raf modulators and methods of use |
| 04/15/2014 | US8697736 1H-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors |
| 04/15/2014 | US8697735 Solid forms of epalrestat |
| 04/15/2014 | US8697733 Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| 04/15/2014 | US8697732 Pyridine derivatives |
| 04/15/2014 | US8697731 Derivatives of 2-pyridin-2-yl-pyrazol-3(2H)-one, preparation and therapeutic use thereof |
| 04/15/2014 | US8697730 5-lipoxygenase activating protein (FLAP) inhibitor |
| 04/15/2014 | US8697728 Perhexiline for use in the treatment of hypertrophic cardiomyopathy (HCM) |
| 04/15/2014 | US8697727 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| 04/15/2014 | US8697726 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics |
| 04/15/2014 | US8697725 Tetrahydroquinoline derivatives and their pharmaceutical use |
| 04/15/2014 | US8697724 Crystalline oxalate salts of a diamide compound |
| 04/15/2014 | US8697722 Nicotinic acetylcholine receptor modulators |
| 04/15/2014 | US8697721 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/15/2014 | US8697720 Substituted phenylether-thienopyridone compounds with antibacterial activity |
| 04/15/2014 | US8697719 Anhydrate of tiotropium bromide |
| 04/15/2014 | US8697718 Pack of medicinal tablets |
| 04/15/2014 | US8697717 Inhibitors of histone deacetylase |